Pharmaceutical company in
Bellinzona

Humabs BioMed SA

Since 2011 · 11–20 empl.

The core activity of Humabs BioMed SA is the discovery and development of anti-infective immunotherapies for the treatment of viral and bacterial diseases, including those caused by Zika, Ebola, Rabies, Dengue and other Flaviviruses. The company focuses on the development of therapeutics up to clinical proof of concept and has a broad pipeline of development candidates.

MADDOX Pharma Swiss GmbH

Since 2015 · 1–10 empl.

MADDOX Pharma Swiss GmbH develops and supplies pharmaceutical products and food supplements. The company describes quality controls and product monitoring throughout the product lifecycle.

MV BioTherapeutics SA

Since 2018 · 11–20 empl.

MV BioTherapeutics SA is a biotherapeutics company developing modified microorganisms and recombinant proteins for therapeutic applications. Its ApyraMed and ApyraVax platforms aim to modulate the intestinal ecosystem and mucosal immune responses, with programs addressing inflammatory bowel disease, cancer immunotherapy and protection against infections.

Peptone Switzerland AG

Since 2022 · 21–50 empl.·3.0(2)

Peptone Switzerland AG develops small-molecule drug candidates targeting intrinsically disordered proteins. The biotechnology company combines experimental measurements of protein dynamics with modelling, computational drug design and biological validation, with research programs spanning oncology, CNS disease, immunology and inflammation.

ASKLEBIO Sagl

Since 2019 · 1–10 empl.

Dynalab Sagl

Since 2019 · 1–10 empl.

CHOOSE LIFE BIOTECH SA

Since 2021 · 1–10 empl.

MicThera Sagl

Since 2023 · 1–10 empl.